While the study of long recovered SUDV survivors was unable to elicit CD8+ T cells, our study demonstrates robust CD8+ T cells against the LFn-EBOV fusion proteins in 3-year post-infection EVD survivors and 2 contacts not known to have ever been infected by EBOV. This evidence concerns the gene CD8A and infection.